In today’s digital-first world, investors expect more than generic thought leadership or one-size-fits-all advice.

When organizations prioritize a clear purpose over profit, they have a positive influence on consumers and stakeholders of ...

Amneal Pharmaceuticals (NYSE:NASDAQ:AMRX), a commercial-stage biopharmaceutical company with a market capitalization of $2.53 billion, has been positioning itself for a new phase of multi-year growth ...

ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...

China, Indonesia, and the U.S. are wrestling with local health issues. China defends its generic drug quality, Indonesia ...

The Danish Health Authority does not want to establish a fixed plan, as a new, serious virus or bacteria may behave in ...

Novartis AG (NYSE:NVS), a global healthcare powerhouse with a market capitalization of $208.27 billion, has recently transformed into a pure-play pharmaceutical company, sharpening its focus on its ...

deep dives into generic leaders—such as Teva, Sandoz, and Viatris—and more. Download the report to learn how to leverage these top companies’ growth plans for your investing strategy.

Palo Alto Networks CEO for the UK and Ireland, Alistair Wildman, discusses cybersecurity in the face of AI and the rise of ...

Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...

Let’s face it: in today’s market, being an excellent lawyer isn’t enough. Your clients aren’t just seeking legal acumen – they’re craving ...

Cencora simplifies distribution logistics by shipping products to centralized wholesaler locations, as opposed to shipping directly to pharmacies and various customer locations. Additionally, Cencora ...